EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Low Molecular Weight Heparin Thromboprophylaxis or No Treatment following Cesarean Delivery: A Pilot Randomized Controlled Trial

Niedermolekulares Heparin zur Thromboseprophylaxe oder keine Behandlung nach Kaiserschnitt: Pilot-RCT

Ann M Bruno, Amanda A Allshouse, D W Branch, Robert M Silver, Torri D Metz

American Journal of Perinatology · 01.07.2026 · 43 (10) · 1328-1334

DOI: 10.1055/a-2753-9286 ↗

Auf einen Blick

In einer Pilotstudie war die Randomisierung zu gewichtsadaptierter LMWH-Prophylaxe nach Kaiserschnitt nicht praktikabel. Die Rekrutierung war zu niedrig, obwohl die Retention hoch war.

Fragestellung

Ist eine Randomisierung zu gewichtsadaptierter LMWH-Prophylaxe versus keiner medikamentösen Thromboseprophylaxe nach Kaiserschnitt praktikabel?

Methode

Einzentrische, offene Pilot-RCT bei Personen ab 18 Jahren nach Kaiserschnitt; Rekrutierung an der University of Utah Health von November 2023 bis Juni 2024; 1:1-Randomisierung zu LMWH für 14 Tage oder keiner medikamentösen Prophylaxe.

Ergebnisse

694 gescreent, 611 angesprochen (88 %, 95 %-KI 85,6–90,5), 64 eingeschlossen (10,5 %, 95 %-KI 8–12,9), 61 behalten (95,3 %, 95 %-KI 90–100). Die Machbarkeitsziele wurden insgesamt nicht erreicht; bei den Zusatzendpunkten gab es keine Unterschiede.

Einschränkungen

Einzentrige Studie; Zielwerte für Einschluss und Retention wurden nicht erreicht.

Schlussfolgerung der Autor:innen

Nach Kaiserschnitt war die individuelle Randomisierung zu gewichtsadaptierter LMWH oder keiner medikamentösen Prophylaxe wegen der niedrigen Rekrutierung nicht machbar.

Kernaussagen

  • Feasibility-Ziel für Rekrutierung nicht erreicht
  • Retentionsrate 95,3 % (95 %-KI 90–100)
  • Keine Unterschiede bei VTE, Wundhämatom, Symptomen oder Blutung

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift American Journal of Perinatology, erschienen am 01.07.2026. Verfasst von Ann M Bruno und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Cesarean Section, Heparin, Low-Molecular-Weight, Venous Thromboembolism, Anticoagulants. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NICHD NIH HHS, National Institute of Child Health and Human Development.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to evaluate the feasibility of randomizing patients to weight-based low molecular weight heparin (LMWH) versus no pharmacologic thromboprophylaxis following cesarean delivery (CD). Single-center, open-label pilot randomized controlled trial of individuals aged 18+ undergoing CD at the University of Utah Health from November 2023 to June 2024. Those with a contraindication to anticoagulation, a plan for therapeutic anticoagulation, or considered at highest risk for postpartum venous thromboembolism (VTE; i.e., undergoing cesarean-hysterectomy, high-risk thrombophilia, personal history of thromboembolism) were excluded. Enrolled individuals were randomized in a 1:1 ratio utilizing block randomization with randomly varying block sizes to receive weight-based LMWH for 14 days or no pharmacologic thromboprophylaxis. The primary outcome was feasibility, defined as ≥35% enrollment of eligible individuals and retention of ≥85% of enrolled individuals through all study procedures. Secondary feasibility outcomes included the number of eligible patients per month, approach rate, enrollment rate, and retention rate. Additional outcomes included VTE, wound hematoma, patient-reported symptoms, or a bleeding complication within 6 weeks postpartum. Baseline characteristics were compared between those approached and enrolled and those not enrolled. The proportion meeting each of the outcomes was reported with 95% confidence intervals (CI). Over the 6-month study period, 694 patients were screened and found eligible for an average of 106 eligible patients per month. There were 611 patients approached (88%, 95% CI: 85.6–90.5), of which 64 enrolled (10.5%, 95% CI: 8–12.9), and 61 participants were retained through all study procedures (95.3%, 95% CI: 90–100). Thus, the overall primary outcome feasibility parameters were not met. Among the 64 individuals enrolled and randomized, the mean age was 31.0 years (standard deviation: 5.5 years), and the majority were non-Hispanic White (56%). Baseline characteristics were similar between those who were approached and enrolled compared with those not enrolled. There were no differences in additional clinical outcomes (VTE, wound hematoma, patient-reported symptoms, or bleeding complications) by prophylaxis group. In this pilot trial, individual patient randomization to weight-based LMWH or no pharmacologic thromboprophylaxis after CD was not feasible due to low enrollment rates. Future trials addressing postpartum thromboembolism prevention should consider alternative study designs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cesarean SectionHeparin, Low-Molecular-WeightVenous ThromboembolismAnticoagulantsPostoperative ComplicationsHumansFemalePilot ProjectsAdultPregnancyFeasibility Studies

Substanzen

Heparin, Low-Molecular-WeightAnticoagulants

Förderung

  • NCATS NIH HHS
  • NICHD NIH HHS
  • National Institute of Child Health and Human Development

Zitieren

APA

Bruno, A. M., Allshouse, A. A., Branch, D. W., Silver, R. M., & Metz, T. D. (2026). Low Molecular Weight Heparin Thromboprophylaxis or No Treatment following Cesarean Delivery: A Pilot Randomized Controlled Trial. American Journal of Perinatology, 43(10), 1328-1334. https://doi.org/10.1055/a-2753-9286

Vancouver

Bruno AM, Allshouse AA, Branch DW, Silver RM, Metz TD. Low Molecular Weight Heparin Thromboprophylaxis or No Treatment following Cesarean Delivery: A Pilot Randomized Controlled Trial. American Journal of Perinatology. 2026;43(10):1328-1334. doi:10.1055/a-2753-9286

BibTeX
@article{Bruno2026,
  author = {Bruno, Ann M and Allshouse, Amanda A and Branch, D W and Silver, Robert M and Metz, Torri D},
  title = {Low Molecular Weight Heparin Thromboprophylaxis or No Treatment following Cesarean Delivery: A Pilot Randomized Controlled Trial},
  journal = {American Journal of Perinatology},
  year = {2026},
  volume = {43},
  number = {10},
  pages = {1328--1334},
  doi = {10.1055/a-2753-9286}
}
Kostenlos starten →